American CryoStem Corporation
Biotechnology Research • 
Eatontown, New Jersey, United States • 11-20 Employees
Company overview
| Headquarters | 1 Meridian Road, Suite 5, Eatontown, NJ 07724, US |
| Phone number | +17327471007 |
| Website | |
| NAICS | 541714 |
| SIC | 283 |
| Keywords | Regenerative Medicine, "Your Cells. Pure And Simple., Atcell Therapies, Atgraft Treatments And Therapies, Autologous Mscs For Post-Concussion Syndrome, Autologous Mesenchymal Stem Cells, End-To-End Proprietary Platform Technology, Tissue Harvesting System, Tissue And Cell Based Therapies, Transport Delivery Direct To Point-Of-Care, Proprietary Cell Transport Media |
| Founded | 2008 |
| Employees | 11-20 |
| Socials |
Key Contact at American CryoStem Corporation
Ruth Goldman
Laboratory Coordinator And Director Of Training
American CryoStem Corporation Email Formats
American CryoStem Corporation uses 5 email formats. The most common is {first name}.{last name}@company.com (e.g., john.doe@company.com), used 42.1% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name}@company.com | john.doe@company.com | 42.1% |
{first name}@company.com | john@company.com | 25.3% |
{first name initial}{last name}@company.com | {first name initial}doe@company.com | 14.8% |
{first name}{last name}@company.com | johndoe@company.com | 10.2% |
{last name}@company.com | doe@company.com | 7.6% |
About American CryoStem Corporation
American CryoStem Corporation (CRYO) is a clinical-stage biotechnology company, developing and delivering autologous (own self) regenerative therapies to treat diseases and conditions with significant unmet medical needs. We are prioritizing research targets and biological drug candidates where the disease biology is understood, and where our suite of technologies has the potential to make a difference. We are currently focused on mitigating the deleterious effects of post-concussion syndrome: https://clinicaltrials.gov/ct2/show/NCT04744051 and Long COVID/ PASC: Post Acute Sequelae of SARS-CoV-2 https://clinicaltrials.gov/ct2/show/NCT05669261 Translating Technology into Therapeutic Treatments™ Our core proprietary "end-to-end" patented technology platform consists of the “Collection-Processing-Cryobanking and Delivery to Point-of-Care” of Adipose Tissue (AT) and Adipose-Derived Mesenchymal Stem Cells (MSCs). Our Platform is configured to produce large quantities of autologous mesenchymal stem cells for treatments as needed, "on-demand". Through a single tissue collection, an autologous master cell sample is manufactured and cryopreserved for a lifetime of personalized treatments. Naturally, pure and simple.™
American CryoStem Corporation revenue & valuation
| Annual revenue | $170,396 |
| Revenue per employee | $9,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $545,267 |
| Total funding | $2,200,000 |
Employees by Management Level
Total employees: 11-20
Seniority
Employees
Employees by Department
American CryoStem Corporation has 10 employees across 6 departments.
Departments
Number of employees
Funding Data
Explore American CryoStem Corporation's funding history, including investment rounds, total capital raised, and key backers.
American CryoStem Corporation Tech Stack
Discover the technologies and tools that power American CryoStem Corporation's digital infrastructure, from frameworks to analytics platforms.
JavaScript libraries
JavaScript libraries
Web servers
WordPress themes
SEO
Font scripts
JavaScript libraries
Programming languages
Blogs
Analytics
SEO
Tag managers
Spain
Hong Kong
Italy
Frequently asked questions
4.8
40,000 users
